Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $41.2600 (2.13%) ($40.4000 - $41.7300) on Wed. Jul. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.07% (three month average) | RSI | 48 | Latest Price | $41.2600(2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) SKYY(7%) VT(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -3.035% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-4%) GDX(-4%) VCSH(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.035% (StdDev 6.07%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
Resistance Level | $41.92 | 5 Day Moving Average | $40.75(1.25%) | 10 Day Moving Average | $40.87(0.95%) | 20 Day Moving Average | $41.92(-1.57%) | To recent high | -13.1% | To recent low | 35.3% | Market Cap | $813m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |